NEW YORK STATE COMMON RETIREMENT FUND - JOUNCE THERAPEUTICS INC ownership

JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 116 filers reported holding JOUNCE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.8%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of JOUNCE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$29
+70.6%
15,4680.0%0.00%
Q4 2022$17
-100.0%
15,4680.0%0.00%
Q3 2022$36,000
-21.7%
15,468
+0.9%
0.00%
Q2 2022$46,000
-55.8%
15,334
-0.2%
0.00%
Q1 2022$104,000
-70.1%
15,372
-63.1%
0.00%
Q4 2021$348,000
+11.2%
41,706
-1.0%
0.00%
Q3 2021$313,000
+9.8%
42,119
+0.5%
0.00%
Q2 2021$285,000
-43.3%
41,921
-14.3%
0.00%
-100.0%
Q1 2021$503,000
+46.6%
48,9340.0%0.00%
Q4 2020$343,000
-15.3%
48,934
-1.4%
0.00%
Q3 2020$405,000
+18.4%
49,6340.0%0.00%
Q2 2020$342,000
+109.8%
49,634
+44.5%
0.00%
Q1 2020$163,000
-15.5%
34,356
+55.2%
0.00%
Q4 2019$193,000
+153.9%
22,134
-2.6%
0.00%
Q3 2019$76,000
-29.0%
22,734
+5.3%
0.00%
Q2 2019$107,000
-21.9%
21,584
-2.3%
0.00%
Q1 2019$137,000
+80.3%
22,084
-1.8%
0.00%
Q4 2018$76,000
-48.6%
22,484
-1.3%
0.00%
Q3 2018$148,000
-15.4%
22,7840.0%0.00%
Q2 2018$175,000
-65.9%
22,784
-0.7%
0.00%
-100.0%
Q1 2018$513,000
+75.7%
22,9340.0%0.00%
Q4 2017$292,000
+239.5%
22,934
+317.0%
0.00%
Q3 2017$86,000
+11.7%
5,5000.0%0.00%
Q2 2017$77,0005,5000.00%
Other shareholders
JOUNCE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
TRV GP II, LLC 9,200,349$64,402,00044.86%
TRV GP III, LLC 3,048,780$21,342,0001.83%
SILVERARC CAPITAL MANAGEMENT, LLC 406,665$2,847,0001.65%
Sofinnova Investments, Inc. 925,280$6,477,0000.39%
Omega Fund Management, LLC 334,965$2,345,0000.35%
Yorktown Management & Research Co Inc 49,200$344,0000.31%
Woodline Partners LP 940,902$6,586,0000.18%
HUSSMAN STRATEGIC ADVISORS, INC. 51,000$357,0000.09%
HORIZON FINANCIAL SERVICES, LLC 12,005$84,0000.08%
Gyon Technologies Capital Management, LP 26,893$188,0000.06%
View complete list of JOUNCE THERAPEUTICS INC shareholders